Quick Takeaways
- Deep Track Capital, LP filed SCHEDULE 13D/A for Dynavax Technologies Corporation Common Stock, par value $0.001 per share (DVAX).
- Disclosed ownership: 14%.
- Date of event: 18 Feb 2025.
Deep Track Capital, LP - 18 Feb 2025 SCHEDULE 13D/A Report for Dynavax Technologies Corporation Common Stock, par value $0.001 per share (DVAX)
- Filing Manager
- Deep Track Capital, LP
- Reporting Manager
- Deep Track Biotechnology Master Fund, Ltd.
- Symbol
- DVAX
- Shares outstanding
- 131,788,785 shares
- Disclosed Ownership
- 17,791,486 shares
- Ownership
- 14%
- Form type
- SCHEDULE 13D/A
- Filing time
- 19 Feb 2025, 21:51:40 UTC
- Date of event
- 18 Feb 2025
- Next filing
- 25 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Deep Track Capital, LP disclosed 14% ownership in Dynavax Technologies Corporation Common Stock, par value $0.001 per share (DVAX) on 18 Feb 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 19 Feb 2025, 21:51.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Deep Track Biotechnology Master Fund, Ltd. | 14% | 17,791,486 | 0 | 17,791,486 | /s/ David Kroin | David Kroin, Director | 0002015536 |
| Deep Track Capital, LP | 14% | 17,791,486 | 0 | 17,791,486 | /s/ David Kroin | David Kroin, Managing Member of the General Partner of Deep Track Capital, LP | 0001856083 |
| David Kroin | 14% | 17,791,486 | 0 | 17,791,486 | /s/ David Kroin | David Kroin | 0001397513 |